- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Youth Tobacco Use in America: An Update
The US Food and Drug Administration, in partnership with the Centers for Disease Control and Prevention, released the results of the 2020 National Youth Tobacco Survey (NYTS) in September 2020. The NYTS is a cross-sectional, school-based, self-administered survey of US middle school (grades 6-8) and high school (grades 9-12) students conducted during January 16-March 16, 2020. The survey assessed current (past 30-day) e-cigarette use and weighted prevalence estimates and population totals were calculated.
The survey showed an encouraging decrease in overall youth e-cigarette use, but also a concerning increase in use of disposable e-cigarettes along with use of fruit and menthol flavored e-cigarettes. In the slides below, find more key takeaways for primary care.
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
October 14th 2025FDA approves updated indication for upadacitinib in ulcerative colitis and Crohn disease treatment, allowing use after one systemic therapy when TNF blockers are clinically inadvisable.
